Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Weisman

Showing results (61-70 of 154) with videos related to

Pageof 16
Sort By:
Health Facilities Management|September 5, 1992
Fewer facilities contract for more 'hotel' servicesE Weisman
Health Facilities Management|October 5, 1994
Will incinerator regs leave your facility holding the (red) bag?E Weisman
Health Facilities Management|May 8, 1992
New fire-safety rules fuel furniture debate: are they worth the cost?E Weisman
Health Facilities Management|February 7, 1993
PPE (personal protective equipment) selection: don't ignore employees' concernsE Weisman
Hospitals|October 20, 1990
Occupational health programs reap profits and referralsE Weisman
Cardiovascular & Hematological Agents in Medicinal Chemistry|August 20, 2009
Respiratory syncytial virus (RSV) prevention and treatment: past, present, and futureLeonard E Weisman
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|October 27, 2007
Antibody for the prevention of neonatal noscocomial staphylococcal infection: a review of the literatureL E Weisman
Current Opinion in Molecular Therapeutics|March 31, 2009
Motavizumab, a second-generation humanized mAb for the prevention of respiratory syncytial virus infection in high-risk populationsLeonard E Weisman
Current Opinion in Infectious Diseases|May 29, 2004
Coagulase-negative staphylococcal disease: emerging therapies for the neonatal and pediatric patientLeonard E Weisman
The Pediatric Infectious Disease Journal|April 3, 2003
Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditionsLeonard E Weisman
Pageof 16

Showing results (61-70 of 154) with videos related to

Sort By:
Pageof 16
Health Facilities Management|September 5, 1992
Fewer facilities contract for more 'hotel' servicesE Weisman
Health Facilities Management|October 5, 1994
Will incinerator regs leave your facility holding the (red) bag?E Weisman
Health Facilities Management|May 8, 1992
New fire-safety rules fuel furniture debate: are they worth the cost?E Weisman
Health Facilities Management|February 7, 1993
PPE (personal protective equipment) selection: don't ignore employees' concernsE Weisman
Hospitals|October 20, 1990
Occupational health programs reap profits and referralsE Weisman
Cardiovascular & Hematological Agents in Medicinal Chemistry|August 20, 2009
Respiratory syncytial virus (RSV) prevention and treatment: past, present, and futureLeonard E Weisman
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|October 27, 2007
Antibody for the prevention of neonatal noscocomial staphylococcal infection: a review of the literatureL E Weisman
Current Opinion in Molecular Therapeutics|March 31, 2009
Motavizumab, a second-generation humanized mAb for the prevention of respiratory syncytial virus infection in high-risk populationsLeonard E Weisman
Current Opinion in Infectious Diseases|May 29, 2004
Coagulase-negative staphylococcal disease: emerging therapies for the neonatal and pediatric patientLeonard E Weisman
The Pediatric Infectious Disease Journal|April 3, 2003
Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditionsLeonard E Weisman
Pageof 16